Profile data is unavailable for this security.
About the company
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
- Revenue in USD (TTM)5.14bn
- Net income in USD551.44m
- Incorporated2016
- Employees18.18k
- LocationSTERIS plcBlock a Riverside IV70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
- Phone+353 12322000
- Websitehttps://www.steris.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Insulet Corp | 1.78bn | 234.00m | 13.78bn | 3.00k | 61.24 | 17.42 | 44.68 | 7.74 | 3.21 | 3.21 | 23.61 | 11.29 | 0.7249 | 1.36 | 6.62 | 593,566.70 | 9.53 | 2.71 | 11.42 | 3.14 | 68.86 | 65.81 | 13.14 | 4.28 | 2.75 | 65.58 | 0.6393 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
Avantor Inc | 6.87bn | 260.00m | 14.27bn | 14.50k | 54.92 | 2.67 | 21.60 | 2.08 | 0.3826 | 0.3826 | 10.12 | 7.86 | 0.525 | 5.32 | 5.71 | 473,565.50 | 1.99 | 2.97 | 2.26 | 3.35 | 33.63 | 33.44 | 3.79 | 5.06 | 1.05 | 3.03 | 0.4994 | 0.00 | -7.26 | 3.51 | -51.52 | -- | 31.17 | -- |
Illumina Inc | 4.49bn | -1.29bn | 16.77bn | 10.59k | -- | 2.92 | -- | 3.73 | -8.15 | -8.15 | 28.39 | 36.06 | 0.4112 | 2.97 | 6.75 | 424,268.20 | -11.80 | -6.20 | -14.21 | -7.28 | 61.36 | 66.39 | -28.69 | -15.48 | 1.36 | -- | 0.2063 | -- | -1.75 | 6.21 | 73.64 | -- | -7.91 | -- |
Baxter International Inc | 14.89bn | -38.00m | 16.90bn | 60.00k | -- | 2.07 | 13.53 | 1.13 | -0.0762 | 5.21 | 29.33 | 16.04 | 0.5311 | 3.21 | 5.71 | 248,200.00 | -0.107 | 0.1942 | -0.1338 | 0.2333 | 36.31 | 38.20 | -0.2015 | 0.3674 | 1.01 | 3.58 | 0.625 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
Cooper Companies Inc | 3.73bn | 339.90m | 17.03bn | 15.00k | 50.27 | 2.18 | 23.58 | 4.56 | 1.70 | 1.70 | 18.68 | 39.19 | 0.3164 | 1.71 | 5.95 | 248,766.70 | 2.88 | 10.06 | 3.13 | 11.34 | 66.23 | 65.54 | 9.11 | 29.00 | 1.14 | 4.98 | 0.258 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
Waters Corp | 2.91bn | 603.51m | 17.05bn | 7.90k | 28.22 | 13.57 | 21.67 | 5.86 | 10.19 | 10.19 | 49.09 | 21.19 | 0.7443 | 2.26 | 4.44 | 368,174.80 | 15.44 | 19.77 | 19.58 | 25.29 | 59.68 | 58.45 | 20.75 | 23.38 | 1.30 | 8.46 | 0.6207 | 0.00 | -0.5229 | 4.09 | -9.26 | 1.53 | 4.72 | -- |
Hologic Inc | 3.96bn | 466.50m | 17.15bn | 6.99k | 37.80 | 3.54 | 21.84 | 4.33 | 1.94 | 1.94 | 16.30 | 20.76 | 0.4361 | 2.66 | 5.82 | 566,609.40 | 5.14 | 11.40 | 5.74 | 13.38 | 55.12 | 60.29 | 11.78 | 20.95 | 3.29 | -- | 0.3465 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
Align Technology, Inc. | 3.92bn | 462.28m | 18.32bn | 21.61k | 40.09 | 4.87 | 30.44 | 4.68 | 6.07 | 6.07 | 51.44 | 49.94 | 0.6497 | 3.96 | 4.27 | 181,237.60 | 7.67 | 16.34 | 11.51 | 24.14 | 70.06 | 71.72 | 11.80 | 23.16 | 1.09 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
Steris PLC | 5.14bn | 551.44m | 21.49bn | 18.18k | 39.10 | 3.41 | 19.21 | 4.18 | 5.56 | 3.81 | 51.79 | 63.73 | 0.4696 | 4.26 | 5.31 | 282,672.40 | 5.06 | 5.19 | 5.51 | 5.68 | 43.17 | 43.64 | 10.77 | 10.97 | 2.36 | 6.75 | 0.3367 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
Zimmer Biomet Holdings Inc | 7.45bn | 963.80m | 21.93bn | 18.00k | 23.07 | 1.74 | 11.40 | 2.94 | 4.62 | 4.62 | 35.72 | 61.24 | 0.3491 | 0.9052 | 5.27 | 414,027.80 | 4.52 | 2.21 | 5.14 | 2.52 | 71.89 | 71.25 | 12.95 | 7.28 | 0.802 | 7.32 | 0.315 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 23.38bn | 10.60k | 42.31 | 8.74 | 33.70 | 7.98 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
Resmed Inc | 4.58bn | 958.38m | 27.82bn | 10.14k | 29.15 | 6.01 | 24.44 | 6.07 | 6.50 | 6.50 | 31.07 | 31.52 | 0.6777 | 2.20 | 5.99 | 452,086.70 | 14.17 | 13.59 | 15.98 | 15.89 | 55.78 | 56.98 | 20.91 | 19.22 | 1.97 | 25.88 | 0.1786 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
Mettler-Toledo International Inc | 3.79bn | 777.86m | 28.92bn | 16.00k | 37.97 | -- | 32.13 | 7.64 | 35.66 | 35.66 | 173.66 | -7.43 | 1.13 | 3.85 | 5.87 | 236,595.00 | 23.24 | 23.32 | 34.14 | 34.02 | 59.25 | 58.58 | 20.55 | 20.51 | 0.7398 | 13.83 | 1.08 | 0.00 | -3.35 | 5.23 | -9.60 | 8.85 | -5.90 | -- |
Veeva Systems Inc | 2.49bn | 555.85m | 29.31bn | 7.17k | 51.83 | 5.99 | 49.73 | 11.78 | 3.50 | 3.50 | 14.80 | 30.25 | 0.4438 | -- | 5.84 | 346,861.80 | 9.92 | 11.97 | 12.38 | 15.36 | 72.48 | 72.00 | 22.34 | 23.74 | -- | -- | 0.00 | 0.00 | 9.68 | 22.35 | 7.79 | 18.00 | 21.68 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 11.42m | 11.54% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 5.80m | 5.87% |
Massachusetts Financial Services Co.as of 31 Mar 2024 | 5.66m | 5.73% |
WCM Investment Management LLCas of 31 Mar 2024 | 4.74m | 4.79% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 4.12m | 4.16% |
APG Asset Management NVas of 31 Mar 2024 | 3.73m | 3.77% |
Morgan Stanley Investment Management Ltd.as of 31 Mar 2024 | 2.79m | 2.82% |
Geode Capital Management LLCas of 31 Mar 2024 | 2.25m | 2.27% |
Generation Investment Management LLPas of 31 Mar 2024 | 2.14m | 2.17% |
Janus Henderson Investors US LLCas of 31 Mar 2024 | 1.99m | 2.01% |